about
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot projectThe human family of Deafness/Dystonia peptide (DDP) related mitochondrial import proteinsA novel X-linked gene, DDP, shows mutations in families with deafness (DFN-1), dystonia, mental deficiency and blindnessStructural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase diseaseRequirement of bic/microRNA-155 for normal immune functionThe landscape of histone modifications across 1% of the human genome in five human cell linesWhole-genome microarrays of fission yeast: characteristics, accuracy, reproducibility, and processing of array dataCharacterization of DRP2, a novel human dystrophin homologueIsolation of cosmid and cDNA clones in the region surrounding the BTK gene at Xq21.3-q22Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cellsFrom genomes to vaccines: Leishmania as a model.Construction of a yeast artificial chromosome contig encompassing the human alpha 5(IV) collagen gene (COL4A5).Expression profiling of the Leishmania life cycle: cDNA arrays identify developmentally regulated genes present but not annotated in the genome.Genomic approaches uncover increasing complexities in the regulatory landscape at the human SCL (TAL1) locus.X inactivation patterns in females with Alport's syndrome: a means of selecting against a deleterious gene?Complex exon-intron marking by histone modifications is not determined solely by nucleosome distribution.Pelizaeus-Merzbacher disease: identification of Xq22 proteolipid-protein duplications and characterization of breakpoints by interphase FISH.Applications of genomic microarrays to explore human chromosome structure and function.Autosomal-dominant microtia linked to five tandem copies of a copy-number-variable region at chromosome 4p16Physical mapping shows close linkage between the alpha-galactosidase A gene (GLA) and the DXS178 locus.Isolation of cDNA clones mapping around DXS178: a search for human X-linked agammaglobulinaemia gene using yeast artificial chromosomes, cosmids and direct cDNA selection.CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression.Identifying gene regulatory elements by genomic microarray mapping of DNaseI hypersensitive sitesBinding sites for metabolic disease related transcription factors inferred at base pair resolution by chromatin immunoprecipitation and genomic microarrays.The chronic myeloid leukemia stem cell: stemming the tide of persistence.DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones.The implications of the cloning of the XLA gene.Functional diversity for REST (NRSF) is defined by in vivo binding affinity hierarchies at the DNA sequence level.Long-range mapping of the gene for the human alpha 5(IV) collagen chain at Xq22-q23.Somatic mosaicism associated with a mild Alport syndrome phenotype.Position effect on PLP1 may cause a subset of Pelizaeus-Merzbacher disease symptoms.The gene involved in X-linked agammaglobulinaemia is a member of the Src family of protein-tyrosine kinases. 1993.Chromatin looping defines expression of TAL1, its flanking genes, and regulation in T-ALL.Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2.Epigenetic dysregulation in chronic myeloid leukaemia: A myriad of mechanisms and therapeutic options.Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition.Cancer: Repositioned to kill stem cells.Gene expression profiling in polycythemia vera using cDNA microarray technology.Identification of deletions in the btk gene allows unambiguous assessment of carrier status in families with X-linked agammaglobulinaemia.Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology
P50
Q21061203-28B2C808-B9D3-4A3D-92C0-56B0103E63AAQ22010769-A4E18301-E7D8-4B9E-90DC-CF18304E65CBQ24311730-98A661E0-A847-4A19-A0EA-C52A5B9380CAQ24564000-0979823D-2A3E-4887-BED9-979EF8D6B69EQ24656120-98A84B17-A7B8-463F-99FF-0ED9C9B2769FQ24673723-13BF2020-2E5A-4837-B481-4DB1DDF7FFC0Q24793500-19B26845-FEC3-4662-9349-20BB61656ECCQ28114838-B77E4BAF-4C7B-47A5-A3C6-8A7355C60168Q28240645-73460BFD-AAC9-4038-AA00-45F8008DC4BAQ28276260-5191EB1D-B10B-4EEF-A8A4-25AE94175313Q30811325-CFD73869-357D-4219-B971-6039B82EB5D5Q30997898-C9969228-96AF-4275-B4D6-4C40B7C02F58Q33202822-1457B8BD-F608-4D52-B6C4-521B7CD97930Q33530093-887D9105-8BF6-409D-A24A-4FA18015E8EDQ33594464-86E78C65-0B13-4B4D-B9D8-784DF8635C09Q33680184-3FFE5E0B-BD7B-41E2-86C4-7611AD3A0CBEQ34386264-8A81DBE4-6DE3-4332-A74B-62D4BDEF42EDQ35883342-4046048B-D4A3-486E-B1C2-0E347999AF03Q36477619-FE420A55-79C8-4260-93D5-020E416E2511Q36741815-07CCF7CF-738B-4CF6-9108-A78056D26B6FQ36748425-79594EAD-9A0C-4C30-A06B-CE21F1D90409Q37638846-36B80E86-DBF6-4B9A-BC09-9BB650868850Q38259609-1AD3EF68-1ACD-4F9F-8233-4832B739A1E9Q38319977-F815C494-8877-479A-9411-604A5A55DD4BQ38761787-B58F7FA0-5A7A-4401-A421-9902FCDADCD5Q40666348-13CB8E22-3E80-4F4A-A36A-72E8810DF230Q40848892-C1EB81E4-A7F2-422A-894F-1582C7DE6B59Q41563633-39AD269E-E3EF-4868-865A-936EC65A854CQ41644559-3B27AA96-D52B-4BE7-97C5-441A3DA5E877Q42844187-6E3F3813-F2F5-4A41-A448-CC714302BB2DQ43073946-ADB71FF8-73BB-4EBA-9165-A1E60D461479Q44835105-7DAD7149-D7B6-4072-AFB4-17B5ADE16D15Q46139802-06556CD8-26C8-4311-822E-3B45DA1585BEQ46803239-3B46191F-9AE8-4AD6-B2E5-67ECF6B1D48FQ47990195-7BD1B793-35DD-4303-BCAE-8636A9732345Q48946028-0F556D25-2B7D-4928-B32E-0703362D2E30Q53359644-52517742-5638-4A6B-85EF-4B90440EE94CQ53980481-5E89B05A-1F0B-4416-BB93-2AA79E318205Q54534920-230A3896-28D4-41FE-A846-D15049FE3536Q57635516-970DF047-4A91-49E0-B9D2-A44C5A1AB249
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
David Vetrie
@ast
David Vetrie
@en
David Vetrie
@es
David Vetrie
@nl
David Vetrie
@sl
type
label
David Vetrie
@ast
David Vetrie
@en
David Vetrie
@es
David Vetrie
@nl
David Vetrie
@sl
prefLabel
David Vetrie
@ast
David Vetrie
@en
David Vetrie
@es
David Vetrie
@nl
David Vetrie
@sl
P106
P21
P31
P496
0000-0003-2075-4662